| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts 01655 [Y. H., C. A. C., D. B. L.] and Molecular Spectroscopy Section [M. C. K.], Southern Research Institute, Birmingham, Alabama 35255-5305
Purified bacterial 3-methyladenine DNA glycosylase II releases four 7-alkylguanines from [3H]N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA: 7-(2-hydroxyethyl)guanine, 1,2-bis(7-guanyl)ethane, 7-(2-chloroethyl)guanine, and 7-(2-ethoxyethyl)guanine. 7-(2-Ethoxyethyl)guanine, a new compound, is formed as a result of an interaction with ethanol, a common solvent for the 2-haloethylnitrosoureas. Of the four 7-alkylguanines which are released from [3H]N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosourea-modified DNA, 7-(2-hydroxyethyl)guanine is released at a rate very much slower than the other three. As shown by a study of the spontaneous decomposition of the corresponding 7-alkyldeoxyguanines, differences in chemical stability do not appear to explain the slow release of 7-(2-hydroxyethyl)guanine.
In view of previous results showing a difference in the distribution of alkylation products between sensitive and resistant glial cell lines, the broad specificity of this enzyme suggests that glycosylase activity could play a role in cellular resistance to 2-haloethylnitrosoureas.
1 Supported by Grants CA-44499 and CA-47103 from the National Cancer Institute. Presented in part at the 80th Annual Meeting of the American Association for Cancer Research, May 1989, San Francisco, CA (11).
2 Present address: Institut Gustave-Roussy, Groupe Radiochimie de l'ADN, Rue Camille Desmoulins, 94805 Villejuif Cedex, France.
3 Present address: Wellcome Research Laboratories, 3030 Cornwallis Road, Research Triangle Park, NC 27709.
4 To whom reprint requests should be addressed, at Department of Pharmacology, University of Massachusetts, Medical Center, 55 Lake Avenue North, Worcester, MA 01655.
Received 6/16/90. Accepted 10/26/90.
This article has been cited by other articles:
![]() |
J. Paik, T. Duncan, T. Lindahl, and B. Sedgwick Sensitization of Human Carcinoma Cells to Alkylating Agents by Small Interfering RNA Suppression of 3-Alkyladenine-DNA Glycosylase Cancer Res., October 15, 2005; 65(22): 10472 - 10477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Li, S. E. Wright, Z. Matijasevic, W. Chong, D. B. Ludlum, and M. R. Volkert The role of human alkyladenine glycosylase in cellular resistance to the chloroethylnitrosoureas Carcinogenesis, March 1, 2003; 24(3): 589 - 593. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Wu, A. Ranasinghe, P. B. Upton, V. E. Walker, and J. A. Swenberg Molecular dosimetry of endogenous and ethylene oxide-induced N7-(2-hydroxyethyl) guanine formation in tissues of rodents Carcinogenesis, September 1, 1999; 20(9): 1787 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al. N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic Cancer Res., February 1, 1999; 59(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |